“
“Objective: To describe experiences with medication therapy management (MTM) services delivered to beneficiaries of
Mirixa’s health plan clients.
Setting: United States during 2007.
Practice description: Three intervention modalities were offered to provide MTM services: community pharmacy, pharmacist-staffed call centers, and educational mailings. Available data were analyzed to identify any differences among patients receiving any of the three interventions. Patients HDAC inhibitor drugs included in the analysis were those who qualified for MTM services between April 1, 2007, and June 30, 2007. MTM services were provided for these patients between May 1, 2007, and December 31, 2007.
Practice innovation: The MirixaPro platform was created to document the activities associated with the five core elements of an MTM service (medication therapy review, creation of a personal medication
record, creation of a medication-related action plan [MAP], intervention and/or referral, and documentation and follow-up). It provides a framework for capturing safety interventions, follow-ups with prescribers, PFTα research buy and pharmacist instructions to the patients.
Main outcome measures: Part D drug costs, use, and generic dispensing ratio in the pre- and post-MTM periods.
Results: 21,336 patients received MTM services from a community pharmacist (face to face, 9,140; by phone, 12,196), 3,436 patients received MTM services from a call center pharmacist, and 49,021 patients received an educational mailing. Patients who had a face-to-face session had a decline in mean monthly drug costs of $29 (from $658 to $629), while drug costs decreased by $40 (from $677 to $637) when the community pharmacist provided the services over the telephone. Mean monthly drug costs decreased by $15 (from $676 to $661) for patients receiving MTM services from a call center pharmacist buy SBC-115076 and did not change for patients receiving an educational mailing ($698 in both periods).
Conclusion: Among patients who received MTM services in 2007, drug costs decreased for those who received service from community pharmacists, decreased somewhat
for patients who received service from a call center pharmacist, and were unchanged for those who received MTM via mailing. Further studies are needed to assess the effect of various types of MTM interventions on financial, clinical, and humanistic outcomes.”
“The objective of this work is to evaluate the impact of 120-W 2-mu m continuous wave (cw) laser vapoenucleation of the prostate in patients with benign prostatic hyperplasia (BPH) on sexual function. One hundred twenty-two consecutive patients with BPH were retrospectively collected in this study and were classified into two groups for surgical treatment with 2-mu m cw laser vapoenucleation or transurethral resection of the prostate (TURP). International Index of Erectile Function (IIEF) and general assessment questions were completed before and 12 months after treatment to determine the impact on sexual function.